GlassScriptPhysician profile
Jordan Loftis
NPI 1477711760
$7,670.59
in general payments reported to CMS, 2019-2025
46 companies · $577 in 2025
The $577 reported for 2025 was more than what 76% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,493 · 2020: $335 · 2021: $244 · 2022: $1,068 · 2023: $1,595 · 2024: $1,359 · 2025: $577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,531.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,531.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $2,022.60 | 2019-2020 | |
| Abbvie INC. | $1,039.91 | 2021-2025 | |
| Novo Nordisk INC | $719.77 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $678.07 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $464.10 | 2020-2025 | Mounjaro, Jardiance, Zepbound |
| Abbott Laboratories | $314.05 | 2022-2024 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $277.29 | 2021-2023 | Shingrix, Arexvy, Trelegy Ellipta |
| Exact Sciences Corporation | $233.16 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $169.74 | 2019-2025 | |
| Intuitive Surgical, INC. | $169.05 | 2019 | |
| Amgen INC. | $149.44 | 2022-2025 | Otezla, Repatha, Repatha |
| Biosense Webster, INC. | $138.05 | 2022 | |
| Pharming Healthcare, INC. | $123.19 | 2023 | Ruconest |
| Biohaven Pharmaceutical Holding Company LTD. | $86.38 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $72.40 | 2019-2024 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Loftis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.